ALEXANDRA MYCOCK: Open Payments
NPI 1679288534 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,088 in 54 payments from 19 companies in 2025. Trend: 2023 $150 · 2024 $585 · 2025 $1,088
Food & beverage: $1,088
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $225 |
| Janssen Biotech, Inc. | 15 | $169 |
| Abbott Laboratories | 1 | $117 |
| Gilead Sciences, Inc. | 4 | $77 |
| GENZYME CORPORATION | 2 | $61 |
| Forte Bio-Pharma LLC | 3 | $60 |
| Atland Pharmaceuticals, LLC | 1 | $55 |
| Aimmune Therapeutics, Inc. | 3 | $53 |
| QOL Medical, LLC | 2 | $45 |
| Alnylam Pharmaceuticals Inc. | 2 | $43 |
Products named: RINVOQ, TREMFYA, PROCLAIM, DUPIXENT, PROLATE, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE, Sucraid, GIVLAARI.
Industry payments across SC — which companies pay providers there.
